What starts as breathlessness can turn fatal within minutes, doctors warn that quick action, correct inhaler use and timely ...

SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...

An asthma attack is a sudden worsening of asthma symptoms caused by inflammation and a narrowing of the airways. This can make breathing difficult and, in severe cases, be life-threatening. Asthma ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Studies have found that emergency room visits for asthma-related problems increase in the winter months. Many asthma sufferers find that winter exacerbates their asthma. But when is an ER visit ...

People using beclometasone inhalers for asthma or other health conditions may want to read up on the NHS guidance for the ...

The treatment, which will be sold under the brand name Exdensur, is an “ultra-long-acting” version of a biologic treatment ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Asthma can be unpredictable, turning everyday activities into challenges when symptoms flare up. Managing asthma at home requires a proactive approach to minimize triggers and maintain a healthy ...

Regarding who can use these inhalers, NHS guidelines state: "Most adults can use beclometasone inhalers for asthma or COPD.

Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...